a 300 billion won venture with drugmaker Quintiles, which on Friday started construction of a biopharmaceutical plant in Korea for commercial production from April 2013. The group's flagship firm, Samsung Electronics, said on Friday it would transfer its...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Samsung SDI says plans $2 bln solar battery investment
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account